Securities and Exchange Commission

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Compare To Other Companies

Annual (shares)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
8,100,000	2012-09-14	10-K	2012	FY	2009-06-29	2010-06-27	CY2009
7,000,000	2013-09-13	10-K	2013	FY	2010-06-28	2011-07-03	CY2011
5,500,000	2013-09-13	10-K	2013	FY	2011-07-04	2012-07-01	CY2012
2,000,000	2013-09-13	10-K	2013	FY	2012-07-02	2013-06-30	CY2013
100,000	2017-09-15	10-K	2017	FY	2014-06-30	2015-06-28	CY2014
100,000	2018-09-14	10-K	2018	FY	2015-06-29	2016-07-03	CY2016
0	2018-09-14	10-K	2018	FY	2016-07-04	2017-07-02	CY2017
0	2018-09-14	10-K	2018	FY	2017-07-03	2018-07-01	CY2018

Quarterly (shares)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
7,100,000	2013-02-08	10-Q	2013	Q2	2011-10-02	2012-01-01	CY2011Q4
5,500,000	2013-05-10	10-Q	2013	Q3	2012-01-02	2012-04-01	CY2012Q1
3,100,000	2013-02-08	10-Q	2013	Q2	2012-10-01	2012-12-30	CY2012Q4
1,800,000	2014-05-09	10-Q	2014	Q3	2012-12-31	2013-03-31	CY2013Q1
1,200,000	2015-02-06	10-Q	2015	Q2	2013-09-30	2013-12-29	CY2013Q4
1,200,000	2015-05-08	10-Q	2015	Q3	2013-12-30	2014-03-30	CY2014Q1
0	2015-11-06	10-Q	2016	Q1	2014-06-30	2014-09-28	CY2014Q3
300,000	2016-02-05	10-Q	2016	Q2	2014-09-29	2014-12-28	CY2014Q4
100,000	2016-05-06	10-Q	2016	Q3	2014-12-29	2015-03-29	CY2015Q1
0	2016-11-14	10-Q	2017	Q1	2015-06-29	2015-09-27	CY2015Q3
100,000	2017-02-10	10-Q	2017	Q2	2015-09-28	2015-12-27	CY2015Q4
100,000	2017-05-12	10-Q	2017	Q3	2015-12-28	2016-03-27	CY2016Q1
0	2017-11-09	10-Q	2018	Q1	2016-07-04	2016-10-02	CY2016Q3
0	2017-02-10	10-Q	2017	Q2	2016-10-03	2017-01-01	CY2016Q4
0	2017-05-12	10-Q	2017	Q3	2017-01-02	2017-04-02	CY2017Q1
0	2017-11-09	10-Q	2018	Q1	2017-07-03	2017-10-01	CY2017Q3
0	2021-11-05	10-Q	2022	Q1	2020-06-29	2020-09-27	CY2020Q3
0	2021-11-05	10-Q	2022	Q1	2021-06-28	2021-09-26	CY2021Q3

All Reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (shares)

Value	Reported On	Form	FY	FP	Start Date	End Date	Fiscal Period
8,100,000	2012-09-14	10-K	2012	FY	2009-06-29	2010-06-27	CY2009
7,000,000	2012-09-14	10-K	2012	FY	2010-06-28	2011-07-03
7,000,000	2013-09-13	10-K	2013	FY	2010-06-28	2011-07-03	CY2011
6,700,000	2013-02-08	10-Q	2013	Q2	2011-07-04	2012-01-01
7,100,000	2013-02-08	10-Q	2013	Q2	2011-10-02	2012-01-01	CY2011Q4
5,600,000	2013-05-10	10-Q	2013	Q3	2011-07-04	2012-04-01
5,500,000	2013-05-10	10-Q	2013	Q3	2012-01-02	2012-04-01	CY2012Q1
5,500,000	2012-09-14	10-K	2012	FY	2011-07-04	2012-07-01
5,500,000	2013-09-13	10-K	2013	FY	2011-07-04	2012-07-01	CY2012
3,400,000	2013-02-08	10-Q	2013	Q2	2012-07-02	2012-12-30
3,400,000	2014-02-07	10-Q	2014	Q2	2012-07-02	2012-12-30
3,100,000	2013-02-08	10-Q	2013	Q2	2012-10-01	2012-12-30	CY2012Q4
3,100,000	2014-02-07	10-Q	2014	Q2	2012-10-02	2012-12-30
3,200,000	2013-05-10	10-Q	2013	Q3	2012-07-02	2013-03-31
3,200,000	2014-05-09	10-Q	2014	Q3	2012-07-02	2013-03-31
1,800,000	2013-05-10	10-Q	2013	Q3	2012-12-31	2013-03-31
1,800,000	2014-05-09	10-Q	2014	Q3	2012-12-31	2013-03-31	CY2013Q1
2,000,000	2013-09-13	10-K	2013	FY	2012-07-02	2013-06-30	CY2013
1,300,000	2014-02-07	10-Q	2014	Q2	2013-07-01	2013-12-29
1,300,000	2015-02-06	10-Q	2015	Q2	2013-07-01	2013-12-29
1,200,000	2015-02-06	10-Q	2015	Q2	2013-09-30	2013-12-29	CY2013Q4
1,200,000	2014-02-07	10-Q	2014	Q2	2013-10-01	2013-12-29
1,200,000	2014-05-09	10-Q	2014	Q3	2013-07-01	2014-03-30
1,200,000	2015-05-08	10-Q	2015	Q3	2013-07-01	2014-03-30
1,200,000	2014-05-09	10-Q	2014	Q3	2013-12-30	2014-03-30
1,200,000	2015-05-08	10-Q	2015	Q3	2013-12-30	2014-03-30	CY2014Q1
0	2015-11-06	10-Q	2016	Q1	2014-06-30	2014-09-28	CY2014Q3
600,000	2015-02-06	10-Q	2015	Q2	2014-06-30	2014-12-28
600,000	2016-02-05	10-Q	2016	Q2	2014-06-30	2014-12-28
300,000	2015-02-06	10-Q	2015	Q2	2014-09-29	2014-12-28
300,000	2016-02-05	10-Q	2016	Q2	2014-09-29	2014-12-28	CY2014Q4
300,000	2015-05-08	10-Q	2015	Q3	2014-06-30	2015-03-29
300,000	2016-05-06	10-Q	2016	Q3	2014-06-30	2015-03-29
100,000	2015-05-08	10-Q	2015	Q3	2014-12-29	2015-03-29
100,000	2016-05-06	10-Q	2016	Q3	2014-12-29	2015-03-29	CY2015Q1
100,000	2017-09-15	10-K	2017	FY	2014-06-30	2015-06-28	CY2014
0	2015-11-06	10-Q	2016	Q1	2015-06-29	2015-09-27
0	2016-11-14	10-Q	2017	Q1	2015-06-29	2015-09-27	CY2015Q3
100,000	2016-02-05	10-Q	2016	Q2	2015-06-29	2015-12-27
100,000	2017-02-10	10-Q	2017	Q2	2015-06-29	2015-12-27
100,000	2016-02-05	10-Q	2016	Q2	2015-09-28	2015-12-27
100,000	2017-02-10	10-Q	2017	Q2	2015-09-28	2015-12-27	CY2015Q4
100,000	2016-05-06	10-Q	2016	Q3	2015-06-29	2016-03-27
100,000	2017-05-12	10-Q	2017	Q3	2015-06-29	2016-03-27
100,000	2016-05-06	10-Q	2016	Q3	2015-12-28	2016-03-27
100,000	2017-05-12	10-Q	2017	Q3	2015-12-28	2016-03-27	CY2016Q1
100,000	2017-09-15	10-K	2017	FY	2015-06-29	2016-07-03
100,000	2018-09-14	10-K	2018	FY	2015-06-29	2016-07-03	CY2016
0	2016-11-14	10-Q	2017	Q1	2016-07-04	2016-10-02
0	2017-11-09	10-Q	2018	Q1	2016-07-04	2016-10-02	CY2016Q3
100,000	2017-02-10	10-Q	2017	Q2	2016-07-04	2017-01-01
0	2017-02-10	10-Q	2017	Q2	2016-10-03	2017-01-01	CY2016Q4
100,000	2017-05-12	10-Q	2017	Q3	2016-07-04	2017-04-02
0	2017-05-12	10-Q	2017	Q3	2017-01-02	2017-04-02	CY2017Q1
0	2017-09-15	10-K	2017	FY	2016-07-04	2017-07-02
0	2018-09-14	10-K	2018	FY	2016-07-04	2017-07-02	CY2017
0	2017-11-09	10-Q	2018	Q1	2017-07-03	2017-10-01	CY2017Q3
0	2018-09-14	10-K	2018	FY	2017-07-03	2018-07-01	CY2018
0	2021-11-05	10-Q	2022	Q1	2020-06-29	2020-09-27	CY2020Q3
0	2021-11-05	10-Q	2022	Q1	2021-06-28	2021-09-26	CY2021Q3